Group One Trading’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Sell
28,900
-94,900
-77% -$306K ﹤0.01% 4848
2026
Q1
$357K Sell
123,800
-231,900
-65% -$913K ﹤0.01% 3646
2025
Q4
$1.45M Buy
355,700
+165,700
+87% +$742K ﹤0.01% 2565
2025
Q3
$675K Buy
190,000
+12,100
+7% +$43.7K ﹤0.01% 3406
2025
Q2
$486K Buy
177,900
+4,600
+3% +$9.49K ﹤0.01% 3458
2025
Q1
$291K Buy
173,300
+14,300
+9% +$40K ﹤0.01% 3635
2024
Q4
$259K Sell
159,000
-60,200
-27% -$180K ﹤0.01% 3735
2024
Q3
$912K Buy
219,200
+192,000
+706% +$1.01M ﹤0.01% 2378
2024
Q2
$149K Buy
27,200
+3,000
+12% +$23.9K ﹤0.01% 3644
2024
Q1
$242K Buy
24,200
+2,300
+11% +$17.2K ﹤0.01% 3389
2023
Q4
$89.4K Buy
21,900
+400
+2% +$1.47K ﹤0.01% 4560
2023
Q3
$83.2K Sell
21,500
-214,800
-91% -$1.15M ﹤0.01% 4623
2023
Q2
$1.41M Buy
+236,300
New +$1.36M ﹤0.01% 2027
2023
Q1
Sell
-1,000
Closed -$3.95K 7863
2022
Q4
$3.95K Buy
+1,000
New +$4.89K ﹤0.01% 6431
2022
Q1
Sell
-1,100
Closed -$17K 8614
2021
Q4
$17K Buy
1,100
+700
+175% +$13.5K ﹤0.01% 7071
2021
Q3
$9K Buy
+400
New +$8.4K ﹤0.01% 7560

Other funds holding SANA

Group One Trading's SANA Position: Q2 2026 in Review

Group One Trading increased its Sana Biotechnology (SANA) stake by 7.5% in Q2 2026, buying an estimated $27.2K and bringing the position to 120,345 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

Group One Trading first reported a position in SANA in Q3 2021 and has held it in 13 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Group One Trading held 120,345 shares of Sana Biotechnology worth $420K as of Q2 2026.
  • Group One Trading bought 8,428 Sana Biotechnology shares in Q2 2026, an estimated $27.2K.
  • Sana Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3654 holding.
  • Group One Trading first reported a position in Sana Biotechnology in Q3 2021 and has held it in 13 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.